 |
 |
 |
Pipeline |
|
|
Interleukin Genetics Incorporated Product Pipeline Analysis
Publication Date August 2008
Publisher Global Markets Direct
Product Type Report
Pages 38
ISBN Number not applicable
Product Code GMD669
|
|
|
Summary
This report is an insightful source for data, analysis and strategic insights into a Interleukin Genetics Incorporated's pipeline and investigational products. The report also provides details on clinical trials covering trial phase, description, investigator information, primary and secondary end-points and trial results for products in development.
Scope
- Details of development stage by sector and equipment type.
- Pipeline products grouped by therapy area, development stage and trial phase.
- Detailed information on clinical trials covering trial phase, description, investigator .nformation, primary and secondary end-points and trial results.
- Trial updates, trial start and end dates, patient numbers and the trials primary outcome measures, secondary outcome measures.
- Product updates covering estimated approval dates and estimated launch dates.
- Descriptions of novel technologies relating to pipeline products of the company.
- Patents and patent applications covered for the product.
- News updates on key events relating to the product and its development.
Reasons to buy
- A single source to fulfill competitor information relating to products in development.
- Identify pipeline products that are potential competitor to your product lines.
Understand a company's strategic position by accessing detailed independent intelligence on its product pipeline.
- Access clinical trial information to map trial results and plan targeted marketing activities.
- Take corrective measures on your own development programs and R&D initiatives based on regulatory events of competitor product pipelines.
- Identification of potential investment opportunities.
- Build up knowledge base for potential distribution and marketing partners.
- Helps avoid patent infringement.
- Timelines from concept to market lets you keep track of market potential build for a new product.
Assess a company's future growth by determining its pipeline depth, for probable acquisition opportunities.
|
Content
- 1 List of Tables
- 2 Company Snapshot
- 2.1 Key Information
- 2.2 Company Overview
- 2.3 Industry Outlook - In Vitro Diagnostics
- 3 Business Description
- 3.1 Business Overview
- 3.2 Major Products and Services
- 4 Competitors
- 5 Key Employees
- 6 Key Employee Biographies
- 7 Company Statement
- 8 Locations And Subsidiaries
- 8.1 Head Office
- 8.2 Other Locations & Subsidiaries
- 9 Recent Developments
- 9.1 Financial Announcements
- 9.1.1 Aug 13, 2008: Interleukin Reports 2Q 2008 Results
- 9.1.2 May 14, 2008: Interleukin Reports Q1 2008 Results
- 9.1.3 Mar 27, 2008: Interleukin Declares Q4 2007 Results
- 9.1.4 Nov 07, 2007: Interleukin Declares Q3 2007 Results
- 9.1.5 Aug 09, 2007: Interleukin Declares Q2 2007 Results
- 9.1.6 May 09, 2007: Interleukin Declares Q1 2007 Results
- 9.1.7 Apr 02, 2007: Interleukin Declares Q4 2006 Results
- 9.1.8 Nov 08, 2006: Interleukin Declares Q3 2006 Results
- 9.2 Corporate Communications
- 9.2.1 Aug 05, 2008: Interleukin Appoints Senior Director, Business Development
- 9.2.2 Jul 28, 2008: Interleukin Announces Board Changes
- 9.2.3 Apr 30, 2008: Interleukin Appoints New CFO
- 9.2.4 Jan 23, 2008: Interleukin Appoints New CEO
- 9.2.5 Sep 06, 2007: Interleukin Announces Management And Board Appointments
- 9.2.6 Jul 03, 2007: Interleukin Announces Executive Management And Board Changes
- 9.3 Product News
- 9.3.1 Aug 13, 2008: Interleukin Genetics Licenses Its PST Genetic Test To OralDNA Labs
- 9.3.2 Jul 22, 2008: Interleukin Genetics Launches Enhanced Heart Health Genetic Test
- 9.3.3 Jun 21, 2006: Interleukin Genetics Licenses DNA-Based Weight Management Technology From GeneOb
- 10 Interleukin Genetics Incorporated Pipeline Products
- 10.1 Interleukin Genetics Incorporated Product Pipeline Analysis
- 10.1.1 Interleukin Genetics Incorporated Pipeline Products By Equipment Type
- 10.1.2 Interleukin Genetics Incorporated Pipeline Products By Development Stage
- 10.1.3 Interleukin Genetics Incorporated Pipeline Products By Therapy Area
- 10.1.4 Interleukin Genetics Incorporated Pipeline Products By News Summary
- 10.2 Osteoporosis genetic test
- 10.2.1 Product Description
- 10.2.2 Product Status
- 10.3 Weight management genetic test
- 10.3.1 Product Description
- 10.3.2 Product Status
- 10.3.3 Product Milestone
- 10.4 Skin Aging genetic test
- 10.4.1 Product Description
- 10.4.2 Product Status
- 10.5 General nutrition genetic test
- 10.5.1 Product Description
- 10.5.2 Product Status
- 10.6 IL1 Cardiovascular genetic test
- 10.6.1 Product Description
- 10.6.2 Product Status
- 11 Appendix
- 11.1 Methodology
- 11.1.1 Coverage
- 11.1.2 Secondary Research
- 11.1.3 Primary Research
- 11.1.4 Expert Panel Validation
- 11.2 Contact Us
- 11.3 About Global Markets Direct
- 11.4 Disclaimer
- 1 List of Tables
- Table 1: Interleukin Genetics Incorporated,Key Facts
- Table 2: Interleukin Genetics Incorporated, Key Employees,
- Table 3: Interleukin Genetics Incorporated, Other Locations
- Table 4: Interleukin Genetics Incorporated Pipeline Products by Equipment Type
- Table 5: Interleukin Genetics Incorporated Pipeline Products By Development Stage
- Table 6: Interleukin Genetics Incorporated Pipeline Products By Therapy Area
- Table 7: Interleukin Genetics Incorporated Pipeline Products By News Summaries
- 1.2 List of Figures
- Figure 1: Interleukin Genetics Incorporated Pipeline Products By Development Stage
- Figure 2: Global Markets Direct Methodology
|
|
| Scope |
Expert Insight/Opinion |
|
| Profiles |
In-depth Company Insight |
|
| Features |
Primary Research Data |
|
|